In 2022, the generative AI healthcare market was worth over $1 billion and is expected to reach nearly $22 billion by 2032. Tech giants, venture capitalists, and private equity firms are heavily involved as investors and innovators. Healthcare companies are partnering with startups to introduce cutting-edge AI technology across healthcare, from research to treatment.